-
Cybin Inc. CEO To Present In Two Upcoming Investor Conferences
Monday, September 27, 2021 - 12:43pm | 1138Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Cybin (NYSE: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, will be participating in two upcoming...
-
Cybin Inc. Likely To Benefit From New Research Touting Psilocybin Mental Health Treatments
Tuesday, September 14, 2021 - 2:08pm | 1022Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Yale researchers publish study that a single dose of psilocybin counteracts symptoms of depression Administering drug to mice resulted...
-
Cybin Inc. (NEO: CYBN) (NYSE: CYBN) Files Two International Patent Applications In Support Of The Company's Research Phase Programs
Thursday, August 19, 2021 - 12:32pm | 935Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Cybin (NEO: CYBN) (NYSE: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has filed two additional...
